We are live on
!
Find out more
GT
Glenmede Trust Portfolio holdings
AUM
$20.4B
This Fund
S&P 500
This Quarter
Est. Return
+6.16%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$25B
AUM Growth
+$2.37B
(+11%)
Cap. Flow
+$1.17B
Cap. Flow
% of AUM
4.67%
Top 10 Holdings %
Top 10 Hldgs %
16.34%
Holding
2,152
New
227
Increased
430
Reduced
632
Closed
714
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$783M |
| 2 |
Genuine Parts
GPC
|
+$573M |
| 3 |
Paychex
PAYX
|
+$431M |
| 4 |
Monster Beverage
MNST
|
+$119M |
| 5 |
Northern Trust
NTRS
|
+$101M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$804M |
| 2 |
Accenture
ACN
|
+$118M |
| 3 |
Sysco
SYY
|
+$76.9M |
| 4 |
Apple
AAPL
|
+$76.7M |
| 5 |
NetApp
NTAP
|
+$69.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.58% |
| 2 | Healthcare | 13.03% |
| 3 | Financials | 12.46% |
| 4 | Consumer Discretionary | 10.73% |
| 5 | Industrials | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1001
Arrowhead Research
ARWR
$12B
| $191K | ﹤0.01% |
10,000
| – | – |
|
1002
Sally Beauty Holdings
SBH
$1.43B
| $191K | ﹤0.01% |
+10,391
| New | +$166K |
|
1003
Cerus
CERS
$615M
| $190K | ﹤0.01% |
26,396
+200
| +0.8% | +$1.45K |
|
1004
Monro
MNRO
$529M
| $190K | ﹤0.01% |
2,742
| – | – |
|
1005
Pultegroup
PHM
$24.9B
| $190K | ﹤0.01% |
7,713
-695,921
| -99% | -$19.7M |
|
1006
Freeport-McMoran
FCX
$90.2B
| $189K | ﹤0.01% |
13,580
-7,271
| -35% | -$110K |
|
1007
Visteon
VC
$2.82B
| $189K | ﹤0.01% |
2,045
+920
| +82% | +$106K |
|
1008
Ralph Lauren
RL
$22.6B
| $187K | ﹤0.01% |
1,367
+7
| +0.5% | +$933 |
|
|
SGEN
1009
DELISTED
Seagen Inc. Common Stock
SGEN
| $185K | ﹤0.01% |
2,400
+2,000
| +500% | +$147K |
|
|
RAVN
1010
DELISTED
Raven Industries Inc
RAVN
| $185K | ﹤0.01% |
4,048
-37
| -0.9% | -$1.57K |
|
1011
Idexx Laboratories
IDXX
$43.9B
| $183K | ﹤0.01% |
737
-20
| -3% | -$4.86K |
|
1012
Dick's Sporting Goods
DKS
$18.4B
| $182K | ﹤0.01% |
5,130
-4,770
| -48% | -$171K |
|
1013
KraneShares CSI China Internet ETF
KWEB
$5.34B
| $182K | ﹤0.01% |
3,755
+1,700
| +83% | +$90.2K |
|
1014
The Mosaic Company
MOS
$7.1B
| $181K | ﹤0.01% |
5,613
+1,856
| +49% | +$55.9K |
|
1015
Ollie's Bargain Outlet
OLLI
$4.04B
| $181K | ﹤0.01% |
1,897
+913
| +93% | +$72.9K |
|
|
TGNA
1016
DELISTED
TEGNA Inc
TGNA
| $181K | ﹤0.01% |
15,206
-6,152
| -29% | -$69.9K |
|
1017
Kinsale Capital Group
KNSL
$8.24B
| $180K | ﹤0.01% |
2,832
| – | – |
|
1018
Patterson-UTI
PTEN
$3.57B
| $180K | ﹤0.01% |
10,546
-3,115
| -23% | -$53.5K |
|
1019
Molson Coors Class B
TAP
$7.71B
| $180K | ﹤0.01% |
2,939
-108
| -4% | -$7.14K |
|
1020
HCA Healthcare
HCA
$86.4B
| $176K | ﹤0.01% |
1,274
+793
| +165% | +$98.7K |
|
|
LOXO
1021
DELISTED
Loxo Oncology, Inc
LOXO
| $176K | ﹤0.01% |
1,040
+50
| +5% | +$8.4K |
|
1022
Sun Life Financial
SLF
$46B
| $174K | ﹤0.01% |
4,384
-843
| -16% | -$33.7K |
|
|
HOLX
1023
DELISTED
Hologic
HOLX
| $172K | ﹤0.01% |
4,232
-968
| -19% | -$39.1K |
|
1024
Zebra Technologies
ZBRA
$12.6B
| $170K | ﹤0.01% |
967
+2
| +0.2% | +$320 |
|
1025
Trip.com Group
TCOM
$28.2B
| $169K | ﹤0.01% |
4,563
-6,533
| -59% | -$265K |
|
Similar funds
SLAM
EWA
MIC
P
OSAM
CB
EIM
Glenmede Trust's Q3 2018 Portfolio in Review
As of Q3 2018, Glenmede Trust held 2,152 positions worth $25B, up 11% from $22.6B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Glenmede Trust deployed $1.17B of net new capital in Q3 2018, opening 227 new positions and adding to 430 existing holdings. Its largest new stake was Vanguard Small-Cap ETF: 518,651 shares worth $84.3M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Johnson & Johnson, an estimated $804M trimmed.
- Glenmede Trust's largest Q3 2018 buy was Vanguard Small-Cap ETF: 518,651 shares worth $84.3M.
- Glenmede Trust added most to Alphabet (Google) Class A in Q3 2018, an estimated $783M increase.
- Glenmede Trust's biggest Q3 2018 reduction was Johnson & Johnson, cutting an estimated $804M.
- Glenmede Trust fully exited BioTelemetry, Inc. in Q3 2018, selling an estimated $43.4M.
- Glenmede Trust's ten largest holdings make up 16% of its $25B portfolio in Q3 2018.
- Glenmede Trust opened 227 new positions and closed 714 in Q3 2018.
- Glenmede Trust's portfolio value rose 11% quarter-over-quarter to $25B.
Based on Glenmede Trust's 13F filing for Q3 2018, filed 15 Nov 2018.